Caplin Point Laboratories Ltd approves Q2 and H1 FY27 results, with consolidated Q2 revenue of ₹629.8 crore and net profit of ₹182.4 crore
- Revenue rose 17.9% YoY and 3.2% QoQ; net profit increased 13.8% YoY and 1.8% QoQ.
- EBITDA margin was 38.7%, versus 38.4% in Q1 FY27 and 38.9% in Q2 FY26.
- No exceptional items were reported; limited-review reports were enclosed.
